Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Millbourn E (1950) On the excretory ducts of the pancreas in man, with special reference to their relations to each other, to the common bile duct and to the duodenum: a radiological and anatomical study. Acta Anat 9:1–34
Doubilet H, Mulholland JH (1951) Intubation of the pancreatic duct in the human. Proc Soc Exp Biol Med 76:113–114
Leger L (1953) Surgical contrast visualization of the pancreatic ducts with a study of pancreatic external secretion. Am J Dig Dis 20:8–12
McCune WS, Shorb PE, Moscovitz H (1968) Endoscopic cannulation of the ampulla of Vater. A preliminary report. Ann Surg 167:752–756
Oi I (1970) Fiberduodenoscopy and endoscopic pancreatocholangiography. Gastrointest Endosc 17:59–62
Takagi K, Ikeda S, Nakagawa Y, et al (1970) Retrograde pancreatography and cholangiography by fiber duodenoscope. Gastroenterology 59:445–452
Adamek HE, Albert J, Breer H, et al (2000) Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 356:190–193
Glasbrenner B, Kahl S, Malfertheiner P (2002) Modern diagnostics of chronic pancreatitis. Eur J Gastroenterol Hepatol 14:935–941
Hawes RH (2002) Diagnostic and therapeutic uses of ERCP in pancreatic and biliary tract malignancies. Gastrointest Endosc 56:S201–205
Adler DG, Baron TH, Davila RE, et al (2005) ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 62:1–8
Yamaguchi T, Shirai Y, Ishihara T, et al (2005) Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy. Cancer 104:2630–2636
Glasbrenner B, Kahl S, Malfertheiner P (2002) Modern diagnostics of chronic pancreatitis. Eur J Gastroenterol Hepatol 14:935–941
Cohen S, Bacon BR, Berlin JA, et al (2002) National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14–16, 2002. Gastrointest Endosc 56:803–809
Etenad B, Whitcomb DC (2001) Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 120:682–707
Nelson DB, Jarvis WR, Rutala WA, et al (2003) Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Gastrointest Endosc 58:1–8
Rey JF, Bjorkman D, Duforest-Rey D, et al (2005) WGOOMGE practice guideline: endoscope disinfection. http://omge.org/globalguidelines/guide14/g_data14_en.htm 14 Dec
Freeman ML (2002) Adverse outcomes of ERCP. Gastrointest Endosc 56:S278–S282
Vandervoort J, Soetikno RM, Tham TC, et al (2002) Risk factors for complications after performance of ERCP. Gastrointest Endosc 56:652–656
Subhani JM, Kibbler C, Dooley JS (1999) Antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 13:103–116
Hirota WK, Petersen K, Baron TH, et al (2003) Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 58:475–482
Rey JR, Axon A, Budzynska A, et al (1998) Guidelines of the European Society of Gastrointestinal Endoscopy (ESGE): antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 30:318–324
Ohto M, Ono T, Tsuchiya Y, Saisho H (1978) Cholangiography and Pancreatography. Igaku-Shoin Tokyo, New York, pp 81–83
Cotton PB (1980) Congenital anomaly of pancreas divisum as cause of obstructive pain and pancreatitis. Gut 21:105–114
Delhaye M, Engelholm L, Cremer M (1985) Pancreas divisum: congenital anatomic variant or anomaly? Contribution of endoscopic retrograde dorsal pancreatography. Gastroenterology 89:951–958
Kalady MF, Peterson B, Baillie J, et al (2004) Pancreatic duct strictures: identifying risk of malignancy. Ann Surg Oncol 11:581–588
Yoshida K, Toki F, Takeuchi T, et al (1995) Chronic Pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568
Pearson RK, Longnecker DS, Chari ST, et al (2003) Controversies in clinical pancreatology: Autoimmune pancreatitis: does it exist? Pancreas 27:1–13
Levy MJ, Wiesema MJ, Chari ST (2006) Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis. Endoscopy 38:530–535
Loperfido S, Angelini G, Benedetti G, et al (1998) Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1–10
Masci E, Toti G, Mariani A, et al (2001) Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96:417–423
Mallery JS, Baron TH, Dominitz JA, et al (2003) Complications of ERCP. Gastrointest Endosc 57:633–638
Cotton PB, Lehman G, Vennes J, et al (1991) Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37:383–393
Freeman ML, Guda NM (2004) Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59:845–864
Freeman ML, DiSario JA, Nelson DB, et al (2001) Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54:425–434
Cavallini G, Tittobello A, Frulloni L, et al (1996) Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 335:919–923
Andriulli A, Leandro G, Niro G, et al (2000) Pharmacologic treatment can prevent pancreatic injury after ERCP: a metaanalysis. Gastrointest Endosc 51:100–103
Arvanitidis D, Anagnostopoulos GK, Giannopoulos D, et al (2004) Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial. J Gastroenterol Hepatol 19:278–282
Andriulli A, Solmi L, Loperfido S, et al (2004) Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2:713–718
Andriulli A, Caruso N, Quitadamo M, et al (2003) Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP 4:41–48
Singh P, Das A, Isenberg G, et al (2004) Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 60:544–550
Fazel A, Quadri A, Catalono MF, et al (2003) Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 57:291–294
Freeman ML, Overby C, Qi D (2004) Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 59:8–14
Harris A, Chan C-H, Torres-Viera C, et al (1999) Metaanalysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP) Endoscopy 31:718–724
Nelson DB (2003) Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc 57:695–711
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Saisho, H. (2008). Endoscopic Retrograde Cholangiopancreatography. In: Beger, H.G., Matsuno, S., Cameron, J.L., Rau, B.M., Sunamura, M., Schulick, R.D. (eds) Diseases of the Pancreas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-28656-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-540-28656-1_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28655-4
Online ISBN: 978-3-540-28656-1
eBook Packages: MedicineMedicine (R0)